Anti-aging injection regrows knee cartilage and prevents arthritis (scitechdaily.com)

Article summary

Researchers at Stanford Medicine have discovered that blocking a protein linked to aging can restore cartilage in aging and injured joints. The treatment, which targets a protein called 15-PGDH, has been shown to regrow cartilage and prevent arthritis in mice, and has also had positive results in human tissue samples. A pill-based version of the therapy is already being tested in clinical trials for treating muscle weakness associated with aging. The findings suggest that cartilage loss due to aging or injury may one day be reversible with a localized injection or oral medication.

Main themes

• Cartilage regeneration
• Aging and osteoarthritis
• Protein therapy
• Joint health
• Clinical trials

What commenters say

• The discovery of a potential treatment for osteoarthritis is exciting, but it is still in the early stages and more research is needed to confirm its effectiveness in humans.
• Some commenters are skeptical about the potential of the treatment, citing the difference between mouse and human biology.
• Others are enthusiastic about the possibility of regrowing cartilage and preventing arthritis, and are eager to participate in clinical trials or learn more about the treatment.
• There is debate about the role of collagen supplements in aiding cartilage health, with some arguing that they can be beneficial and others questioning the evidence.
• The treatment's potential to improve quality of life for people with osteoarthritis is significant, and could potentially reduce the need for joint replacement surgery.
• Some commenters are concerned about the accessibility and affordability of the treatment, should it become available.
• The discussion highlights the complexity of joint health and the need for further research into the underlying mechanisms of osteoarthritis and potential treatments.